These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches. Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412 [TBL] [Abstract][Full Text] [Related]
7. Treatment of mice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum. Yao J; Wang JY; Lai MG; Li YX; Zhu HM; Shi RY; Mo J; Xun AY; Jia CH; Feng JL; Wang LS; Zeng WS; Liu L Mol Pharm; 2011 Apr; 8(2):488-97. PubMed ID: 21271712 [TBL] [Abstract][Full Text] [Related]
8. A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. Yan S; Yang B; Zhao J; Zhao J; Stanton C; Ross RP; Zhang H; Chen W Food Funct; 2019 Mar; 10(3):1595-1608. PubMed ID: 30806428 [TBL] [Abstract][Full Text] [Related]
9. Li M; Ding J; Stanton C; Ross RP; Zhao J; Yang B; Chen W Food Funct; 2023 Jan; 14(1):354-368. PubMed ID: 36511157 [No Abstract] [Full Text] [Related]
11. Bifidobacterium longum and VSL#3 Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219 [TBL] [Abstract][Full Text] [Related]
12. Colonization of C57BL/6 Mice by a Potential Probiotic Bifidobacterium bifidum Strain under Germ-Free and Specific Pathogen-Free Conditions and during Experimental Colitis. Grimm V; Radulovic K; Riedel CU PLoS One; 2015; 10(10):e0139935. PubMed ID: 26439388 [TBL] [Abstract][Full Text] [Related]
14. Probiotic bacteria lactobacillus and bifidobacterium attenuate inflammation in dextran sulfate sodium-induced experimental colitis in mice. Toumi R; Soufli I; Rafa H; Belkhelfa M; Biad A; Touil-Boukoffa C Int J Immunopathol Pharmacol; 2014; 27(4):615-27. PubMed ID: 25572742 [TBL] [Abstract][Full Text] [Related]
15. Viability Status-Dependent Effect of Pyclik MJ; Srutkova D; Razim A; Hermanova P; Svabova T; Pacyga K; Schwarzer M; Górska S Front Immunol; 2021; 12():707728. PubMed ID: 34354710 [TBL] [Abstract][Full Text] [Related]
16. Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis. Celiberto LS; Bedani R; Dejani NN; Ivo de Medeiros A; Sampaio Zuanon JA; Spolidorio LC; Tallarico Adorno MA; Amâncio Varesche MB; Carrilho Galvão F; Valentini SR; Font de Valdez G; Rossi EA; Cavallini DCU PLoS One; 2017; 12(4):e0175935. PubMed ID: 28437455 [TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory Bifidobacterium strains prevent dextran sodium sulfate induced colitis and associated gut microbial dysbiosis in mice. Singh S; Bhatia R; Khare P; Sharma S; Rajarammohan S; Bishnoi M; Bhadada SK; Sharma SS; Kaur J; Kondepudi KK Sci Rep; 2020 Oct; 10(1):18597. PubMed ID: 33122795 [TBL] [Abstract][Full Text] [Related]
18. The Probiotic, ID-JPL934, Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice Through Inhibition of Proinflammatory Cytokines Expression. Je IG; Lee DG; Jeong DG; Hong D; Yoon JM; Moon JS; Park S J Med Food; 2018 Sep; 21(9):858-865. PubMed ID: 30036104 [TBL] [Abstract][Full Text] [Related]